Water Affordability, Transparency, Equity, and Reliability Act of 2021

HR 1352, S 916- Water Affordability, Transparency, Equity and Reliability (WATER) Act HR 4597- Clean Water State Revolving Fund Parity Act

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act); provisions related to the taxation of tobacco products S.1314/H.R. 2786, Tobacco Tax Equity Act of 2021 H.R. 5376 - Build Back Better Act--provisions related to the taxation of tobacco products and nicotine, federal vapor tax policy, and tobacco drawback Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Issues surrounding taxation of tobacco products

Client expense: $620,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Outreach related to taxation of tobacco products. S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act), provisions related to the taxation of tobacco products. H.R. 5376 - Inflation Reduction Act, provisions related to the taxation of tobacco products.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6985- Financing Lead Out of Water (FLOW) Act HR 1352, S 916- Water Affordability, Transparency, Equity and Reliability (WATER) Act HR 4597- Clean Water State Revolving Fund Parity Act

Client expense: $470,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; H.R. 3282 - Drinking Water Funding for the Future Act of 2021; H.R. 1352 (Lawrence)/S. 916 (Sanders) - Water Affordability, Transparency, Equity, and Reliability Act of 2021

Client expense: $180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act); provisions related to the taxation of tobacco products S.1314/H.R. 2786, Tobacco Tax Equity Act of 2021 H.R. 5376 - Build Back Better Act--provisions related to the taxation of tobacco products and nicotine, federal vapor tax policy, and tobacco drawback Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Issues surrounding taxation of tobacco products

Client expense: $680,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Bills: H.R. 1915 - Water Quality Protection and Job Creation Act of 2021; S. 101 - Environmental Justice Mapping and Data Collection Act of 2021; H.R. 1512 - Climate Leadership and Environmental Action for our Nations Future Act (CLEAN Future Act); H.R. 3293 - Low-Income Water Customer Assistance Programs Act of 2021; S. 872 - Environmental Justice for All Act; S. 2454 - Water Reuse and Resiliency Act of 2021; H.R. 3282 - Drinking Water Funding for the Future Act of 2021; S. 914 (Duckworth) - Drinking Water and Wastewater Infrastructure Act of 2021; H.R. 1352 (Lawrence)/S. 916 (Sanders) - Water Affordability, Transparency, Equity, and Reliability Act of 2021

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 6985- Financing Lead Out of Water (FLOW) Act HR 1352, S 916- Water Affordability, Transparency, Equity and Reliability (WATER) Act HR 4597- Clean Water State Revolving Fund Parity Act

Client expense: $510,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Outreach related to taxation of tobacco products. S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act), provisions related to the taxation of tobacco products. H.R. 5376 - Build Back Better Act, provisions related to the taxation of tobacco products.

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act); provisions related to the taxation of tobacco products S.1314/H.R. 2786, Tobacco Tax Equity Act of 2021 H.R. 5376 - Build Back Better Act--provisions related to the taxation of tobacco products and nicotine, federal vapor tax policy, and tobacco drawback Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Issues surrounding taxation of tobacco products

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

NACD advocated against the reinstatement of the Superfund tax in H.R.3684 - Infrastructure Investment and Jobs Act as a pay-for. The Superfund Tax on chemicals is being sold as a fee on chemicals, but it is really a new tax on consumers. The 42 chemicals identified for taxation are the building blocks for a limitless number of goods, including steel, plastics, wood products, copper, cement, glass, pesticides, fungicides, pharmaceuticals, rubber, paint and coatings, batteries, solar panels, soap and detergents, ceramics, textiles, semiconductors, water treatment, light bulbs, refrigerants, dental fillings, fireworks and consumer electronics. The Superfund Tax on chemicals will also impede the goals of the Bipartisan Infrastructure Framework by making the components of infrastructure more expensive-including clean energy building blocks such as renewable energy, advanced coatings, energy efficiency solutions and electric vehicle (EV) infrastructure. The Superfund Tax on chemicals will also make U.S. manufacturers less competitive. Additionally, NACD advocated against the inclusion of broad environmental programs that would be duplicative to current federal agencies' efforts. Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills introduced in the 117th Congress and opposed to include: S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ), and H.R. 2467 - introduced by Rep. Debbie Dingell (D-MI). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

In opposition to the legislation surrounding the reinstatement of the Superfund excise tax. Specifically, reinstating the Superfund tax in H.R.3684 - Infrastructure Investment and Jobs Act. Additionally, NACD advocated against the inclusion of broad environmental programs that would be duplicative to current federal agencies' efforts. Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills introduced in the 117th Congress and opposed to include: S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ), and H.R. 2467 - introduced by Rep. Debbie Dingell (D-MI). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act); provisions related to the taxation of tobacco products S.1314/H.R. 2786, Tobacco Tax Equity Act of 2021 H.R. 5376 - Build Back Better Act--provisions related to the taxation of tobacco products and nicotine, federal vapor tax policy, and tobacco drawback Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Issues surrounding taxation of tobacco products

Client expense: $750,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Assist the organization with budgeting issues pertaining to healthcare, education and clean water preservations as it specifically relates to the welfare of Children; S.3062 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act 2022; S.1907 Clean Water Standards for PFAS Act of 2021; H.R.4597 Clean Water SRF Parity Act; H.R.898 Care for COVID-19 Act of 2021; H.R.796 Coverage for COVID-19 Treatment Act of 2021; H.R.710 Coronavirus Containment Corps Act; S.631 COVID-19 Mental Health Research Act; H.R.616 Emergency Water is a Human Right Act; HR 794 & S938 Climate Emergency Act of 2021; S.916 Water Affordability, Transparency, Equity, and Reliability Act of 2021; H.R.3751 Clean Water Infrastructure Resilience and Sustainability Act of 2021

Client expense: Not reported · Firm income: $5,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 916/H.R. 1897, Mothers and Offspring Mortality and Morbidity Awareness Act (MOMMAS Act); provisions related to the taxation of tobacco products S.1314/H.R. 2786, Tobacco Tax Equity Act of 2021 H.R. 5376 - Build Back Better Act Discussions concerning draft legislation to amend corporate tax rates and federal excise taxes on tobacco products Issues surrounding taxation of tobacco products

Client expense: $740,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Assist the organization with budgeting issues pertaining to healthcare, education and clean water preservations as it specifically relates to the welfare of Children. H.R.898 Care for COVID-19 Act of 2021; H.R.796 Coverage for COVID-19 Treatment Act of 2021; H.R.710 Coronavirus Containment Corps Act; S.631 COVID-19 Mental Health Research Act; H.R.616 Emergency Water is a Human Right Act; H.R.4502 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022; HR 794 & S938 Climate Emergency Act of 2021; S.916 Water Affordability, Transparency, Equity, and Reliability Act of 2021; H.R.3751 Clean Water Infrastructure Resilience and Sustainability Act of 2021

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.916- Water Affordability, Transparency, Equity, and Reliability Act of 2021; H.R.1512 - CLEAN Future Act

Client expense: $10,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills introduced in the 117th Congress and opposed to include: S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ), and H.R. 2467 - introduced by Rep. Debbie Dingell (D-MI). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

Client expense: $40,000 · Firm income: Not reported

Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills introduced in the 117th Congress and opposed to include: S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ), and H.R. 2467 - introduced by Rep. Debbie Dingell (D-MI). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

Client expense: $40,000 · Firm income: Not reported

Assist the organization with budgeting issues pertaining to healthcare, education and clean water preservations as it specifically relates to the welfare of Children. H.R.898 Care for COVID-19 Act of 2021; H.R.796 Coverage for COVID-19 Treatment Act of 2021; H.R.710 Coronavirus Containment Corps Act; S.631 COVID-19 Mental Health Research Act; H.R.616 Emergency Water is a Human Right Act; 1. H.R.4502 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022; HR 794 & S938 Climate Emergency Act of 2021; S.916 Water Affordability, Transparency, Equity, and Reliability Act of 2021.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HOUSE: H.R. 2644 Green New Deals for Cities Act of 2021 (Support) SENATE: Eliminating the Filibuster (Support) S. 874 BUILD GREEN Infrastructure and Jobs Act (Support) S. 4887 End Polluter Welfare Act of 2020 (Support) S. 916 Water Affordability, Transparency, Equity, and Reliability Act of 2021 (Support) S.Res. 166 A resolution recognizing the duty of the Federal Government to create a Green New Deal. (Support) HOUSE and SENATE: H.R. 2919 and S. 1525 Transform, Heal, and Renew By Investing in a Vibrant Economy ("THRIVE") Act (Support) S. 1244 and H.R. 2670 Civilian Climate Corps for Jobs and Justice Act (Support) S. 1218 and H.R. 2664 Green New Deal for Public Housing Act (Support) NOT YET INTRODUCED: Voting Rights Advancement Act (Support) American Renewable Energy Act (Support) EJ Legacy Pollution Cleanup Act (Support) Renewable Portfolio Standard (Support)

Client expense: $18,500 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills include introduced in the 117th Congress include S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, and H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

Client expense: $40,000 · Firm income: Not reported

Legislation surrounding the regulation of PFAS chemicals. Including that the federal government should implement a consistent approach for assessing and regulating specific PFAS with clear timelines, regulations should be based on sound science, specific PFAS compounds should be regulated based on risk to protect human health and the environment, PFAS chemistries should be regulated independently - not as a single group, and Congress should provide regulatory agencies with the proper oversight and funding necessary to evaluate and address specific priority PFAS. Bills include introduced in the 117th Congress include S. 1121 - PFAS Registry Act introduced by Senator Shaheen (D-NH), H.R. 3291 - introduced by Rep. Paul Tonko (D-NY), S. 916/H.R. 1352 - Water Affordability, Transparency, Equity, and Reliability Act of 2021 introduced by Sen. Sanders (I-VT) in the US Senate and Rep. Brenda Lawrence (D-MI) in the US House of Representatives, and H.R. 1512 - Clean Future Act introduced by Rep. Frank Pallone (D-NJ). Legislation surrounding the regulation of ethylene oxide. Opposition to H.R. 314 - Communities and Environment First Act of 2021 introduced by Rep. Cedric Richmond (D-LA) as it relates to an increased excise tax on ethylene, S. 984 - Break Free From Plastics Pollution Act of 2021 introduced by Senator Jeff Merkley (D-OR) as it relates to ethylene product classification, and H.R. 1512 - CLEAN Future Act introduced by Rep. Frank Pallone (D-NJ) as it relates to ethylene product classification.

Client expense: $40,000 · Firm income: Not reported

  S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2185, Quit Because of COVID-19 Act 116th Congress H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act S. 2463, E-Cigarette Tax Parity Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 2519, Ending New Nicotine Dependencies (ENND) Act S. 3263/H.R. 5845, Break Free from Plastic Pollution Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding taxation of tobacco products Issues surrounding tobacco harm reduction Issues surrounding vaccine development Issues surrounding efforts to prevent youth access to tobacco products January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Client expense: $490,000 · Firm income: Not reported